Get the Stockscreener App
422.99
1.17%
-5.00
After Hours:
421.98
-1.01
-0.24%
Overview
News
Price History
Option Chain
Financials
Why MSFT Down?
Discussions
Forecast
Stock Split
Dividend History
Microsoft Corporation stock is traded at $422.99, with a volume of 17.36M.
It is down -1.17% in the last 24 hours and down -1.21% over the past month.
See More
Previous Close:
$427.99
Open:
$425.105
24h Volume:
17.36M
Relative Volume:
0.93
Market Cap:
$3.22T
Revenue:
$254.19B
Net Income/Loss:
$90.51B
P/E Ratio:
40.95
EPS:
10.33
Net Cash Flow:
$72.66B
1W Performance:
+1.81%
1M Performance:
-1.21%
6M Performance:
-1.67%
1Y Performance:
+11.72%
1-Day Range:
$422.02
$427.23
1-Week Range:
$410.29
$429.04
52-Week Range:
$362.90
$468.35
Microsoft Corporation Stock (MSFT) Company Profile
Name
Microsoft Corporation
Sector
Industry
Phone
425-882-8080
Address
ONE MICROSOFT WAY, REDMOND, WA
Compare MSFT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MSFT
Microsoft Corporation
|
422.99 | 3.22T | 254.19B | 90.51B | 72.66B | 10.33 |
|
ORCL
Oracle Corp
|
182.70 | 512.04B | 53.82B | 10.98B | 11.27B | 3.36 |
|
ADBE
Adobe Inc
|
513.68 | 224.24B | 20.95B | 5.36B | 6.55B | 11.11 |
|
PLTR
Palantir Technologies Inc
|
66.05 | 149.76B | 2.65B | 476.57M | 980.32M | 0.06 |
|
CRWD
Crowdstrike Holdings Inc
|
347.59 | 84.74B | 3.52B | 170.20M | 1.11B | -0.408 |
Microsoft Corporation Stock (MSFT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-24 | Reiterated | BMO Capital Markets | Outperform |
| Oct-10-24 | Reiterated | Goldman | Buy |
| Oct-08-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-23-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jun-10-24 | Initiated | New Street | Buy |
| Jun-07-24 | Reiterated | Oppenheimer | Outperform |
| Apr-17-24 | Reiterated | Wells Fargo | Overweight |
| Apr-12-24 | Reiterated | BMO Capital Markets | Outperform |
| Apr-11-24 | Reiterated | Morgan Stanley | Overweight |
| Mar-21-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Jan-18-24 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Dec-13-23 | Initiated | Truist | Buy |
| Dec-05-23 | Initiated | China Renaissance | Buy |
| Oct-26-23 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-17-23 | Initiated | Loop Capital | Buy |
| Sep-25-23 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-15-23 | Initiated | HSBC Securities | Hold |
| Jul-24-23 | Reiterated | Goldman | Buy |
| Jul-24-23 | Reiterated | Raymond James | Outperform |
| Jul-21-23 | Reiterated | Goldman | Buy |
| Jul-19-23 | Reiterated | Barclays | Overweight |
| Jul-19-23 | Reiterated | BofA Securities | Buy |
| Jul-19-23 | Reiterated | Mizuho | Buy |
| Jul-19-23 | Reiterated | TD Cowen | Outperform |
| Jul-19-23 | Reiterated | Wells Fargo | Overweight |
| Jul-17-23 | Reiterated | Mizuho | Buy |
| Jul-14-23 | Upgrade | UBS | Neutral → Buy |
| Jul-13-23 | Reiterated | Oppenheimer | Outperform |
| Apr-26-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Apr-26-23 | Reiterated | Goldman | Buy |
| Apr-26-23 | Reiterated | Guggenheim | Sell |
| Apr-26-23 | Reiterated | JP Morgan | Overweight |
| Apr-26-23 | Reiterated | Jefferies | Buy |
| Apr-26-23 | Upgrade | Macquarie | Neutral → Outperform |
| Apr-26-23 | Reiterated | Mizuho | Buy |
| Apr-26-23 | Reiterated | MoffettNathanson | Market Perform |
| Apr-26-23 | Reiterated | Morgan Stanley | Overweight |
| Apr-26-23 | Reiterated | Oppenheimer | Outperform |
| Apr-26-23 | Reiterated | Piper Sandler | Overweight |
| Apr-26-23 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-26-23 | Reiterated | Raymond James | Outperform |
| Apr-26-23 | Reiterated | Rosenblatt | Buy |
| Apr-26-23 | Reiterated | Stifel | Buy |
| Apr-26-23 | Reiterated | TD Cowen | Outperform |
| Apr-26-23 | Reiterated | UBS | Neutral |
| Apr-26-23 | Reiterated | Wedbush | Outperform |
| Apr-26-23 | Reiterated | Wells Fargo | Overweight |
| Apr-26-23 | Reiterated | Wolfe Research | Outperform |
| Apr-24-23 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Apr-21-23 | Reiterated | BMO Capital Markets | Market Perform |
| Apr-20-23 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-19-23 | Reiterated | BofA Securities | Buy |
| Apr-19-23 | Reiterated | Citigroup | Buy |
| Apr-19-23 | Reiterated | Deutsche Bank | Buy |
| Jan-25-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-17-23 | Downgrade | Guggenheim | Neutral → Sell |
| Jan-05-23 | Initiated | DA Davidson | Buy |
| Jan-04-23 | Downgrade | UBS | Buy → Neutral |
| Nov-02-22 | Initiated | Macquarie | Neutral |
| Oct-14-22 | Reiterated | Morgan Stanley | Overweight |
| Sep-30-22 | Resumed | Raymond James | Outperform |
| Sep-22-22 | Initiated | MoffettNathanson | Hold |
| Aug-12-22 | Initiated | Guggenheim | Neutral |
| Jul-27-22 | Reiterated | BMO Capital Markets | Outperform |
| Jul-27-22 | Reiterated | Citigroup | Buy |
| Jul-27-22 | Reiterated | Cowen | Outperform |
| Jul-27-22 | Reiterated | Deutsche Bank | Buy |
| Jul-27-22 | Reiterated | Stifel | Buy |
| Jul-27-22 | Reiterated | Wedbush | Outperform |
| Jul-26-22 | Initiated | Itau BBA | Outperform |
| Jul-19-22 | Reiterated | Citigroup | Buy |
| Jun-29-22 | Initiated | Redburn | Buy |
| Apr-27-22 | Reiterated | BMO Capital Markets | Outperform |
| Apr-27-22 | Reiterated | Deutsche Bank | Buy |
| Apr-27-22 | Reiterated | Evercore ISI | In-line |
| Apr-27-22 | Reiterated | Stifel | Buy |
| Apr-27-22 | Reiterated | Wedbush | Outperform |
| Apr-27-22 | Reiterated | Wolfe Research | Outperform |
| Jan-26-22 | Reiterated | BMO Capital Markets | Outperform |
| Jan-26-22 | Reiterated | Citigroup | Buy |
| Jan-26-22 | Reiterated | Morgan Stanley | Overweight |
| Jan-26-22 | Reiterated | Oppenheimer | Outperform |
| Jan-12-22 | Reiterated | BMO Capital Markets | Outperform |
| Dec-22-21 | Initiated | SMBC Nikko | Outperform |
| Nov-22-21 | Initiated | Wells Fargo | Overweight |
| Nov-16-21 | Resumed | Credit Suisse | Outperform |
| Nov-02-21 | Initiated | Deutsche Bank | Buy |
| Oct-27-21 | Reiterated | Barclays | Overweight |
| Oct-27-21 | Reiterated | BofA Securities | Buy |
| Oct-27-21 | Reiterated | Cowen | Outperform |
| Oct-27-21 | Reiterated | Credit Suisse | Outperform |
| Oct-27-21 | Reiterated | Goldman | Buy |
| Oct-27-21 | Reiterated | Mizuho | Buy |
| Oct-27-21 | Reiterated | Morgan Stanley | Overweight |
| Oct-27-21 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-21 | Reiterated | Stifel | Buy |
| Sep-17-21 | Resumed | Rosenblatt | Buy |
| Sep-14-21 | Reiterated | Morgan Stanley | Overweight |
| Aug-20-21 | Reiterated | Mizuho | Buy |
| Jul-28-21 | Reiterated | Barclays | Overweight |
| Jul-28-21 | Reiterated | Bernstein | Outperform |
| Jul-28-21 | Reiterated | BofA Securities | Buy |
| Jul-28-21 | Reiterated | Citigroup | Buy |
| Jul-28-21 | Reiterated | Cowen | Outperform |
| Jul-28-21 | Reiterated | Credit Suisse | Outperform |
| Jul-28-21 | Reiterated | Griffin Securities | Buy |
| Jul-28-21 | Reiterated | Mizuho | Buy |
| Jul-28-21 | Reiterated | Morgan Stanley | Overweight |
| Jul-28-21 | Reiterated | Piper Sandler | Overweight |
| Jul-28-21 | Resumed | RBC Capital Mkts | Outperform |
| Jul-28-21 | Reiterated | Rosenblatt | Buy |
| Jul-28-21 | Reiterated | Stifel | Buy |
| Jul-28-21 | Reiterated | Wolfe Research | Outperform |
| Jul-22-21 | Reiterated | BofA Securities | Buy |
| Jul-22-21 | Reiterated | Citigroup | Buy |
| Jul-22-21 | Reiterated | Cowen | Outperform |
| Jul-22-21 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jun-23-21 | Reiterated | Wedbush | Outperform |
| May-13-21 | Initiated | Rosenblatt | Buy |
| Apr-23-21 | Initiated | Wolfe Research | Outperform |
| Apr-12-21 | Reiterated | BMO Capital Markets | Outperform |
| Apr-05-21 | Resumed | Credit Suisse | Outperform |
| Mar-16-21 | Resumed | Credit Suisse | Outperform |
| Mar-03-21 | Resumed | Citigroup | Buy |
| Jan-26-21 | Resumed | Raymond James | Strong Buy |
| Jan-22-21 | Initiated | Goldman | Buy |
| Dec-21-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-16-20 | Resumed | BofA Securities | Buy |
| Nov-24-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-14-20 | Resumed | UBS | Buy |
| Jul-23-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-20-20 | Reiterated | Stifel | Buy |
| Jul-15-20 | Reiterated | BMO Capital Markets | Outperform |
| Jul-09-20 | Reiterated | Wedbush | Outperform |
| Jun-24-20 | Reiterated | Argus | Buy |
| Jun-02-20 | Reiterated | Wells Fargo | Overweight |
| May-27-20 | Initiated | Summit Insights | Buy |
| Apr-30-20 | Reiterated | Griffin Securities | Buy |
| Jan-30-20 | Reiterated | Oppenheimer | Outperform |
| Jan-30-20 | Reiterated | Piper Sandler | Overweight |
| Jan-30-20 | Reiterated | RBC Capital Mkts | Outperform |
| Jan-30-20 | Reiterated | Raymond James | Strong Buy |
| Jan-30-20 | Reiterated | Stifel | Buy |
| Jan-30-20 | Reiterated | Wedbush | Outperform |
| Jan-30-20 | Reiterated | Wells Fargo | Overweight |
View All
Microsoft Corporation Stock (MSFT) Latest News
FTC Opens Microsoft Antitrust Investigation - Bloomberg
FTC Investigates Microsoft's (MSFT) Antitrust Practices in Cloud and AI Sectors - GuruFocus.com
FTC launches antitrust investigation into Microsoft as Biden era ends - The Washington Post
F.T.C. Launches Antitrust Investigation Into Microsoft - The New York Times
Factbox-US regulator opens wide-ranging antitrust probe into Microsoft By Reuters - Investing.com
Elon Musk questions Microsoft’s hiring practices over unverified X post - The American Bazaar
FTC reportedly launches antitrust investigation into Microsoft's cloud, AI and cybersecurity practices - SiliconANGLE News
Microsoft Antitrust Investigation: FTC Launches Large-Scale Probe Into Tech Giant - Forbes
Microsoft’s Antitrust Luck Runs Out - The Information
Microsoft faces wide-ranging US antitrust probe - Reuters
FTC opens wide-ranging antitrust probe into Microsoft - Yahoo Finance UK
FTC opens investigation into Microsoft’s practices - KIRO Seattle
FTC launches broad investigation into Microsoft: Bloomberg By Investing.com - Investing.com
Microsoft is being investigated by the FTC over antitrust concerns - The Verge
Microsoft (MSFT) Projected to Hit New High of $550: Is Now the Time to Buy In? - Watcher Guru
Microsoft faces wide-ranging U.S. antitrust probe - The Globe and Mail
Microsoft (MSFT) Targeted in U.S. Antitrust Case - TipRanks
Microsoft slides after FTC launches antitrust investigation: report - Seeking Alpha
FTC allegedly opens antitrust probe into Microsoft - baha news
"We are eager to launch and give more choice and flexibility to players": Microsoft delays new Xbox Android app features on Google Play due to court order - Windows Central
SoftBank Considers $1.5B Investment in Microsoft Corporation (MSFT)-Backed OpenAI Through Tender Offer - Yahoo Finance
FTC opened antitrust investigation into Microsoft, Bloomberg reports - TipRanks
Microsoft Is Denying That Office 365 Trains Its AI - Lifehacker
Microsoft Faces Broad Antitrust Investigation From US FTC - Bloomberg
US Antitrust Watchdog Launches Broad Microsoft Investigation - Bloomberg Law
Microsoft (NASDAQ:MSFT) Shares Down 0.9%What's Next? - MarketBeat
Microsoft denies training AI models on user data - Yahoo Canada Finance
Microsoft negotiates joining Brazil's sovereign cloud project - BNamericas English
Microsoft Denies Training AI on Customer Data Following Uproar - Bloomberg Law
Microsoft Promises It Isn't Using Office Docs to Train AI - ExtremeTech
Microsoft confirms it doesn't use your Office docs to train AI - Android Headlines
Microsoft launches $4M bug bounty challenge to secure AI, cloud - SC Media
Is Alphabet Stock Too Cheap to Ignore? - The Motley Fool
Microsoft Stock Gets a $550 Price Target: Time to Get Excited - MarketBeat
12 STUDENTS EARN MICROSOFT CERTIFICATION - WiscNews
Microsoft hits back at claims it slurps your Word, Excel files to train AI models - The Register
Microsoft Says It Doesn’t Use Your Office Docs to Train Its AI - Beebom
Microsoft denies it’s collecting user data in Word and Excel - Techzine Europe
Don't trust everything you hear. Microsoft does NOT use your data from Microsoft 365 to train AI models. - Windows Central
Get a Microsoft Office 2019 license for Mac or Windows for 85% off with this deal - ZDNet
Are Office docs being used to train AI? Microsoft responds - NewsBytes
Are Microsoft 365 and Outlook down? Thousands report outage Monday morning - USA TODAY
Microsoft clarifies it does not use your Office documents to train AI models - Neowin
Microsoft Releases Recall in Windows Insider Preview - Dark Reading
Microsoft Office AI training report is based on a misunderstanding, says the company - 9to5Mac
Microsoft and Coles Ink $5 Billion AI Deal to Revolutionize Retail Tech - Yahoo Finance
What is Microsoft Places? AI Workplace Coordination - UC Today
Microsoft Corporation (MSFT): Partners with Coles Group for 5-Year Cloud and AI Deal to Enhance IT Infrastructure - Yahoo Finance
Microsoft Corp (MSFT) and NowVertical Group Partner: Boosting AI Data Solutions with Azure - Insider Monkey
Microsoft outage disrupts Outlook and Teams, affecting thousands - MSN
No, Microsoft isn’t using your Office docs to train its AI - The Verge
Microsoft Corporation Stock (MSFT) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.03%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):